Use of src sh2 specific compounds to treat a bone resorption...

Details Use of src sh2 specific compounds to treat a bone resorption... Use of src sh2 specific compounds to treat a bone resorption...

A - Human Necessities

61

K

A61K 31/165 (2006.01) A61K 31/12 (2006.01) A61K 31/166 (2006.01) A61K 31/195 (2006.01) A61K 31/40 (2006.01) A61K 31/437 (2006.01) A61K 31/50 (2006.01)

Patent

CA 2169136

Invented is a method of treating a bone resorption disease in a subject which comprises administering to the subject a therapeutically effective amount of a compound which binds to a human src SH2 domain with a binding affinity greater than fifty-fold higher than the binding affinity with which the compound binds to a human lck SH2 domain and a human fyn SH2 domain, and, binds to a human hcp SH2 domain, a human Grb2 SH2 domain, a human SH-PTP2 SH2 domain and a human p85 SH2 domain with a binding affinity which is greater than fifty-fold lower than the binding affinity with which the compound binds to such src SH2 domain.

Affiliated with

Also associated with

Rating

Use of src sh2 specific compounds to treat a bone resorption... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of src sh2 specific compounds to treat a bone resorption..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of src sh2 specific compounds to treat a bone resorption... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1594005